Tetraphase Pharmaceuticals News

WATERTOWN, Mass. -- -- Tetraphase Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on next-generation antibiotics, announced today that it is presenting new results from studies that demonstrate the improved potency and pharmacokinetics of several of its newest discovery-stage tetracycline analogs.

Tetraphase Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on next-generation antibiotics, announced today that it is presenting new results from studies that demonstrate the improved potency and pharmacokinetics of several of its newest discovery-stage tetracycline analogs.

WATERTOWN, Mass. -- -- Tetraphase Pharmaceuticals , Inc., a clinical-stage life science company developing a portfolio of potent new antibiotics designed to be effective against dangerous, drug-resistant bacteria gram-negative pathogens), today announced that the Company will present at the 11th Annual Needham Healthcare Conference .

WATERTOWN, Mass. -- -- Tetraphase Pharmaceuticals , Inc., a clinical-stage life science company developing a portfolio of potent new antibiotics designed to be effective against dangerous, drug-resistant bacteria gram-negative pathogens), today announced that the Company will present at the Cowen and Company 32nd Annual Health Care Conference.